EGFR Inhibitor
CAS: 879127-07-8
Ref. 3D-EKB12707
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
EGFR Inhibitor is a drug that inhibits the epidermal growth factor receptor (EGFR) and prevents the activation of the EGFR. This drug is used to treat cancer, such as lung cancer and pancreatic cancer. EGFR inhibitors are drugs that inhibit the epidermal growth factor receptor (EGFR). EGFR inhibitors can be classified into two groups: tyrosine kinase inhibitors and monoclonal antibodies. The most common EGFR inhibitor is erlotinib (Tarceva), which is used for treating lung cancer, pancreatic cancer, head and neck cancers, and other types of cancers. Gefitinib (Iressa) is another type of EGFR inhibitor that has been shown to be effective against colorectal cancer.
Chemical properties
Technical inquiry about: 3D-EKB12707 EGFR Inhibitor
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
